InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,274.56
(
-0.59%
)
US TECH 100
18,306.00
(
-0.44%
)
Dow Jones
38,525.53
(
-0.84%
)
Brent Oil
83.46
(
-1.03%
)
Bitcoin
67,434.58
(
-1.25%
)
Post# of 396422
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BottomBounce

Send PM Follow Ignore
Followers 898
Posts 149010
Boards Moderated 0
Alias Born 08/13/2010

BottomBounce

Re: Psionic Trader post# 375401

Saturday, 09/06/2014 8:10:29 AM

Saturday, September 06, 2014 8:10:29 AM

Post# of 396422
$GE Healthcare announced EU approval of Vizamyl
GE Healthcare announced that Vizamyl has received marketing authorization from the European Commission as a radiopharmaceutical medicinal product indicated for Positron Emission Tomography imaging of beta amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease and other causes of cognitive impairment. Vizamyl is the only PET imaging tracer for detection of amyloid approved in Europe for visual interpretation of colour images and will be commercially available in selected European countries from early 2015, GE said. http://online.wsj.com/article/PR-CO-20140901-905507.html

I am NOT a Financial Adviser. Nothing I say, post, or do should be considered financial advice. I may be holding a long, short or no position. I am NOT compensated to post on here and all my posts are for entertainment purposes only.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up